SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(De Backer Guy) "

Sökning: WFRF:(De Backer Guy)

  • Resultat 1-10 av 42
  • [1]2345Nästa
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Tidskriftsartikel (refereegranskat)
  •  
2.
  • Tidskriftsartikel (refereegranskat)
  •  
3.
  •  
4.
  • Bentham, James, et al. (författare)
  • A century of trends in adult human height
  • 2016
  • Ingår i: eLIFE. - 2050-084X. ; 5
  • Tidskriftsartikel (refereegranskat)abstract
    • Being taller is associated with enhanced longevity, and higher education and earnings. We reanalysed 1472 population-based studies, with measurement of height on more than 18.6 million participants to estimate mean height for people born between 1896 and 1996 in 200 countries. The largest gain in adult height over the past century has occurred in South Korean women and Iranian men, who became 20.2 cm (95% credible interval 17.522.7) and 16.5 cm (13.319.7) taller, respectively. In contrast, there was little change in adult height in some sub-Saharan African countries and in South Asia over the century of analysis. The tallest people over these 100 years are men born in the Netherlands in the last quarter of 20th century, whose average heights surpassed 182.5 cm, and the shortest were women born in Guatemala in 1896 (140.3 cm; 135.8144.8). The height differential between the tallest and shortest populations was 19-20 cm a century ago, and has remained the same for women and increased for men a century later despite substantial changes in the ranking of countries.
  •  
5.
  • De Bacquer, Dirk, et al. (författare)
  • Incidence of cardiovascular events in patients with stabilized coronary heart disease : the EUROASPIRE IV follow-up study
  • 2021
  • Ingår i: European Journal of Epidemiology. - : Springer. - 0393-2990. ; 34:3, s. 247-258
  • Tidskriftsartikel (refereegranskat)abstract
    • The EUROASPIRE surveys (EUROpean Action on Secondary Prevention through Intervention to Reduce Events) demonstrated that most European coronary patients fail to achieve lifestyle, risk factor and therapeutic targets. Here we report on the 2-year incidence of hard cardiovascular (CV) endpoints in the EUROASPIRE IV cohort. EUROASPIRE IV (2012–2013) was a large cross-sectional study undertaken at 78 centres from selected geographical areas in 24 European countries. Patients were interviewed and examined at least 6 months following hospitalization for a coronary event or procedure. Fatal and non-fatal CV events occurring at least 1 year after this baseline screening were registered. The primary outcome in our analyses was the incidence of CV death or non-fatal myocardial infarction, stroke or heart failure. Cox regression models, stratified for country, were fitted to relate baseline characteristics to outcome. Our analyses included 7471 predominantly male patients. Overall, 222 deaths were registered of whom 58% were cardiovascular. The incidence of the primary outcome was 42 per 1000 person-years. Comorbidities were strongly and significantly associated with the primary outcome (multivariately adjusted hazard ratio HR, 95% confidence interval): severe chronic kidney disease (HR 2.36, 1.44–3.85), uncontrolled diabetes (HR 1.89, 1.50–2.38), resting heart rate ≥ 75 bpm (HR 1.74, 1.30–2.32), history of stroke (HR 1.70, 1.27–2.29), peripheral artery disease (HR 1.48, 1.09–2.01), history of heart failure (HR 1.47, 1.08–2.01) and history of acute myocardial infarction (HR 1.27, 1.05–1.53). Low education and feelings of depression were significantly associated with increased risk. Lifestyle factors such as persistent smoking, insufficient physical activity and central obesity were not significantly related to adverse outcome. Blood pressure and LDL-C levels appeared to be unrelated to cardiovascular events irrespective of treatment. In patients with stabilized CHD, comorbid conditions that may reflect the ubiquitous nature of atherosclerosis, dominate lifestyle-related and other modifiable risk factors in terms of prognosis, at least over a 2-year follow-up period.
  •  
6.
  • De Smedt, Delphine, et al. (författare)
  • Cost-effectiveness of optimized adherence to prevention guidelines in European patients with coronary heart disease : Results from the EUROASPIRE IV survey
  • 2018
  • Ingår i: International Journal of Cardiology. - : Elsevier. - 0167-5273 .- 1874-1754. ; 272, s. 20-25
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: This study aims to assess the cost-effectiveness of optimized guideline adherence in patients with a history of coronary heart disease. Methods: An individual-based decision tree model was developed using the SMART risk score tool which estimates the 10-year risk for recurrent vascular events in patients with manifest cardiovascular disease (CVD). Analyses were based on the EUROASPIRE IV survey. Outcomes were expressed as an incremental cost-effectiveness ratio (ICER). Results: Data from 4663 patients from 13 European countries were included in the analyses. The mean estimated 10-year risk for a recurrent vascular event decreased from 20.13% to 18.61% after optimized guideline adherence. Overall, an ICER of 52,968€/QALY was calculated. The ICER lowered to 29,093€/QALY when only considering high-risk patients (≥20%) with decreasing ICERs in higher risk patients. Also, a dose-response relationship was seen with lower ICERs in older patients and in those patients with higher risk reductions. A less stringent LDL target (<2.5 mmol/L vs. <1.8 mmol/L) lowered the ICER to 32,591€/QALY and intensifying cholesterol treatment in high-risk patients (≥20%) instead of high-cholesterol patients lowered the ICER to 28,064€/QALY. An alternative method, applying risk reductions to the CVD events instead of applying risk reductions to the risk factors lowered the ICER to 31,509€/QALY. Conclusion: Depending on the method used better or worse ICERs were found. In addition, optimized guidelines adherence is more cost-effective in higher risk patients, in patients with higher risk reductions and when using a less strict LDL-C target. Current analyses advice to maximize guidelines adherence in particular patient subgroups.
  •  
7.
  •  
8.
  •  
9.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 42
  • [1]2345Nästa
Typ av publikation
tidskriftsartikel (39)
forskningsöversikt (3)
Typ av innehåll
refereegranskat (40)
övrigt vetenskapligt (2)
Författare/redaktör
De Backer, Guy (40)
Cifkova, Renata (19)
Dallongeville, Jean (16)
Banegas, José R (13)
De Backer, G (13)
Reiner, Željko (12)
visa fler...
Fagard, Robert (12)
Mancia, Giuseppe (12)
Cifkova, R (11)
Laurent, Stephane (11)
Kjeldsen, Sverre E (11)
Ryden, Lars (10)
Zamorano, Jose Luis (10)
Redon, Josep (10)
Perk, Joep (10)
Guallar, Eliseo (10)
Borghi, Claudio (10)
Manolis, Athanasios ... (10)
Rydén, L. (9)
Nilsson, Peter M (9)
Rodríguez-Artalejo, ... (9)
Graham, Ian (9)
Narkiewicz, Krzyszto ... (9)
Schmieder, Roland E. (9)
Dominiczak, Anna (9)
Amouyel, Philippe (8)
Reiner, Z (8)
Wood, D (8)
Viigimaa, Margus (8)
Halcox, Julian P (8)
Pajak, A (8)
Wood, David (8)
Tendera, Michal (7)
Dean, Veronica (7)
Amouyel, P (7)
Zannad, Faiez (7)
Pajak, Andrzej (7)
De Bacquer, D. (7)
Funck-Brentano, Chri ... (7)
Zanchetti, Alberto (7)
Ruilope, Luis (7)
Germano, Giuseppe (7)
Perk, Joep, 1945- (6)
De Smedt, D (6)
Grobbee, Diederick E ... (6)
Tubach, Florence (6)
Roy, Carine (6)
De Bacquer, Dirk (6)
Kotseva, K (6)
Tokgözoğlu, Lale (6)
visa färre...
Lärosäte
Linnéuniversitetet (15)
Lunds universitet (12)
Karolinska Institutet (11)
Göteborgs universitet (7)
Umeå universitet (5)
Uppsala universitet (4)
visa fler...
Linköpings universitet (4)
Högskolan Dalarna (1)
visa färre...
Språk
Engelska (41)
Italienska (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (33)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy